Skip to content

CTEV CTEV Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
Corvel logo
CorvelCRVL
Cognizant logo
CognizantCTSH
Phreesia logo
PhreesiaPHR
Waystar Holding Corp. logo
Waystar Holding Corp.WAY
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B
P/S0.6×

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by CTEV in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's operating lease right-of-use assets in other assets?
CTEV (CTEV) reported operating lease right-of-use assets in other assets of $13.55M in Q1 2026.
How has CTEV's operating lease right-of-use assets in other assets changed year-over-year?
CTEV's operating lease right-of-use assets in other assets increased by 12.0% year-over-year, from $12.1M to $13.55M.
What is the long-term trend for CTEV's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), CTEV's operating lease right-of-use assets in other assets has grown at a -14.9% compound annual growth rate (CAGR), from $31.34M to $13.97M.